Modulation of rat rotational behavior by direct gene transfer of constitutively active protein kinase C into nigrostriatal neurons.
The modulation of motor behavior by protein kinase C (PKC) signaling pathways in nigrostriatal neurons was examined by using a genetic intervention approach. Herpes simplex virus type 1 (HSV-1) vectors that encode a catalytic domain of rat PKCbetaII (PkcDelta) were developed. PkcDelta exhibited a constitutively active protein kinase activity with a substrate specificity similar to that of rat brain PKC. As demonstrated in cultured sympathetic neurons, PkcDelta caused a long-lasting, activation-dependent increase in neurotransmitter release. In the rat brain, microinjection of HSV-1 vectors that contain the tyrosine hydroxylase promoter targeted expression to dopaminergic nigrostriatal neurons. Expression of pkcDelta in a small percentage of nigrostriatal neurons (approximately 0.1-2%) was sufficient to produce a long-term (>/=1 month) change in apomorphine-induced rotational behavior. Nigrostriatal neurons were the only catecholaminergic neurons that contained PkcDelta, and the amount of rotational behavior was correlated with the number of affected nigrostriatal neurons. The change in apomorphine-induced rotational behavior was blocked by a dopamine receptor antagonist (fluphenazine). D2-like dopamine receptor density was increased in those regions of the striatum innervated by the affected nigrostriatal neurons. Therefore, this strategy enabled the demonstration that a PKC pathway or PKC pathways in nigrostriatal neurons modulate apomorphine-induced rotational behavior, and altered dopaminergic transmission from nigrostriatal neurons appears to be the affected neuronal physiology responsible for the change in rotational behavior.
Song
S
S
Division of Endocrinology, Children's Hospital, Boston, Massachusetts 02115, USA.
Wang
Y
Y
Bak
S Y
SY
During
M J
MJ
Bryan
J
J
Ashe
O
O
Ullrey
D B
DB
Trask
L E
LE
Grant
F D
FD
O'Malley
K L
KL
Riedel
H
H
Goldstein
D S
DS
Neve
K A
KA
LaHoste
G J
GJ
Marshall
J F
JF
Haycock
J W
JW
Neve
R L
RL
Geller
A I
AI
D000818:Animals; D001058:Apomorphine; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology*; D002395:Catecholamines / Q000378:metabolism; D003342:Corpus Striatum / Q000166:cytology; D004279:DNA, Viral / Q000032:analysis; D018491:Dopamine Agonists; D005347:Fibroblasts / Q000502:physiology; D015971:Gene Expression Regulation, Enzymologic; D018014:Gene Transfer Techniques; D018259:Herpesvirus 1, Human; D008636:Mesencephalon; D009474:Neurons / Q000201:enzymology*; D017354:Point Mutation; D011493:Protein Kinase C / Q000235:genetics*; D012333:RNA, Messenger / Q000032:analysis; D011817:Rabbits; D051381:Rats; D011994:Recombinant Proteins / Q000235:genetics; D012399:Rotation; D013378:Substantia Nigra / Q000166:cytology; D013379:Substrate Specificity; D009435:Synaptic Transmission / Q000187:drug effects
D002395:Catecholamines; D004279:DNA, Viral; D018491:Dopamine Agonists; D012333:RNA, Messenger; D011994:Recombinant Proteins; D011493:Protein Kinase C; D001058:Apomorphine